Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY) -- Ignore unavailable to you. Want to Upgrade?

To: hoyasaxa who wrote (1239)	12/2/1999 5:31:00 PM
From: si2000	Respond to of 3202

Excellent article (written prior to today's release) on CRA, INCY and the race to obtain proprietary rights to gene sequences in the latest issue of Next Wave Stocks: "Race to Decode Human Genome as Volatile as Biotech Stocks" By Carolyn Marshall at nextwavestocks.com If the 50,000 number reported today proves accurate, it underscores just how fast things are changing. While you're at Next Wave Stocks, check out their many resources for the high tech/biotech investor: the Next Wave 100 index which includes a Bio/Med Technology Sector, several relevant directories and databases, a comprehensive calendar of industry investment conferences and insightful articles.